Clinical Cardiac Rehabilitation Registry Study

National Center for Cardiovascular Diseases

Status: Not yet enrolling

Conditions: Cardiac Rehabilitation

Study type: Observational

Funder types: Other

Identifiers

NCT05808751

2022-1785

Details and patient eligibility

About

Establish an electronic cardiac rehabilitation patient registration system and clinical database, carry out prospective cohort follow-up and observation of cardiovascular disease (CVD) patients receiving cardiac rehabilitation in inpatients and outpatients, collect risk factors, diagnosis and treatment status, rehabilitation diagnosis and treatment, clinical outcomes and follow-up results, and establish a short-term and long-term follow-up mechanism.

Full description

Establish an electronic cardiac rehabilitation patient registration system and clinical database, carry out prospective cohort follow-up and observation of cardiovascular disease (CVD) patients receiving cardiac rehabilitation in inpatients and outpatients, collect risk factors, diagnosis and treatment status, rehabilitation diagnosis and treatment, clinical outcomes and follow-up results, and establish a short-term and long-term follow-up mechanism. Through the real world clinical practice data of cardiac rehabilitation of CVD patients, describe the population and disease characteristics of cardiac rehabilitation patients, the provision of cardiac rehabilitation services and the influencing factors; Analyze and study the key technologies of clinical cardiac rehabilitation, evaluate the implementation quality of cardiac rehabilitation, improve the clinical pathway of cardiac rehabilitation, and optimize the service process.

Enrollment: 2,081 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. 18 years of age and older.
2. Patients receiving inpatient cardiac rehabilitation, and/or participating in outpatient cardiac rehabilitation.
3. All cases selected were in New York Heart Association (NYHA) cardiac function class II and below.
4. Normal troponin.
5. Patients with some ability to communicate and understand.
6. have signed an informed consent form. -

Exclusion criteria

1. Subjects who are participating in clinical trials of other drugs or devices.
2. Patients with NYHA cardiac function class III or higher.
3. Mentally impaired, or unable to communicate effectively with investigators.
4. Refusal to sign the informed consent form.